+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotype characteristics of skin dendritic cells in patients with psoriatic arthritis during the treatment with deresinated naphthalan



Phenotype characteristics of skin dendritic cells in patients with psoriatic arthritis during the treatment with deresinated naphthalan



Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2001(4): 29-32



The study of the phenotype of immunocompetent dendritic cells of the skin in patients with psoriatic arthritis in the course of treatment with deresinated naphthalan (DRN) has revealed some aspects of the mechanism of therapeutic action of DRN. Use of the complex of monoclonal antibodies allowed the authors to determine membrane markers of various cells belonging to the system of mononuclear phagocytes and participating in development of immunoinflammation in the skin. The active stage of the disease is characterized by a fall in the number of CDIa+ cells. HLA-DR+ cells are more resistant. DRN therapy led to prevalence of CDIa+ cells.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973640

Download citation: RISBibTeXText

PMID: 11561301


Related references

Keratinocyte immunophenotypes in patients with psoriatic arthritis and their changes after treatment with deresinated naphthalan. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2001(6): 32-34, 2001

Deresinated naphthalan in the treatment of psoriatic arthritis. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1994(4): 13-15, 1994

Immunological phenotype of skin lymphoid cells in patients with psoriatic arthritis during rehabilitation. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2003(5): 8-12, 2003

The effect of the ultraphonophoesis of deresinated naphthalan in patients with a history of exudative pleurisy. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1995(6): 18-20, 1995

The cerebral hemodynamics in patients with humeroscapular periarthritis under the influence of decimeter waves and deresinated naphthalan. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1993(5): 34-38, 1993

The clinical and neuromediator mechanisms of the analgetic action of decimeter waves and deresinated naphthalan in patients with humeroscapular periarthrosis. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1992(4): 21-25, 1992

The combined use of electromagnetic decimeter waves and deresinated naphthalan in patients with vertebrogenic humeroscapular periarthrosis (its experimental and clinical validation). Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1994(4): 9-12, 1994

Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry. Journal of the European Academy of Dermatology and Venereology 31(6): 1021-1028, 2017

Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Human Immunology 60(6): 479-491, 1999

A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)). Clinical Rheumatology 34(8): 1407-1412, 2015

Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care and Research 69(11): 1692-1699, 2017

Identification and characterization of plasmacytoid dendritic cells in the synovial fluid from patients with rheumatoid and psoriatic arthritis. Journal of Interferon and Cytokine Research 22(Suppl. 1): S-83, 2002

Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin. British Journal of Dermatology 165(4): 792-801, 2011

UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. Journal of Investigative Dermatology 95(3): 275-282, 1990

THU0427Sustained Improvements in Skin Outcomes Following Certolizumab Pegol Treatment of Psoriatic Arthritis Patients with Prior Anti-TNF Exposure or Severe Skin Involvement at Baseline. Annals of the Rheumatic Diseases 74(Suppl 2): 353.2-354, 2015